Organism: Homo sapiens
Gene: 1186_at
Selected probe(set): 206159_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 1186_at (206159_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):5.798103
Number of Samples:6 / 6

Experimental	TC-71
	Human primary cancer cell line derived from the humerus of a patient with Ewing sarcoma. Synonyms:TC71; GM11654 Cellosaurus code:
Control	TC-32
	Human primary cancer cell line derived from the unspecified origin of a patient with Ewing’s sarcoma. Synonyms:TC32 Cellosaurus code:

Relative Expression (log2-ratio):5.156665
Number of Samples:2 / 2

Experimental	expO stomach cancer study 1 (gastrointestinal stromal tumor; primary)
	Primary tumor tissue samples obtained from the stomach of patients with gastrointestinal stromal tumor.
Control	expO stomach cancer study 1 (Signet ring cell carcinoma; primary)
	Primary tumor tissue samples obtained from the stomach of patients with Signet ring cell carcinoma.

Relative Expression (log2-ratio):5.110979
Number of Samples:2 / 3

Experimental	expO stomach cancer study 1 (gastrointestinal stromal tumor; primary)
	Primary tumor tissue samples obtained from the stomach of patients with gastrointestinal stromal tumor.
Control	expO stomach cancer study 1 (adenocarcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the stomach of patients with adenocarcinoma (NOS).

Relative Expression (log2-ratio):-4.299781
Number of Samples:34 / 46

Experimental	brain tumor study 1 (glioblastoma)
	Primary tumor tissue sample from the brain of patients with glioblastoma multiformae.
Control	brain tumor study 1 (ependymoma)
	Primary tumor tissue sample from the brain of patients with ependymoma.

Relative Expression (log2-ratio):-3.4716234
Number of Samples:22 / 46

Experimental	brain tumor study 1 (medulloblastoma)
	Primary tumor tissue sample from the brain of patients with medulloblastoma.
Control	brain tumor study 1 (ependymoma)
	Primary tumor tissue sample from the brain of patients with ependymoma.

Relative Expression (log2-ratio):-3.4514446
Number of Samples:6 / 20

Experimental	lung adenocarcinoma study 6 (K-RAS mut)
	Primary tumor sample from patients with stage II adenocarcinoma carrying a K-RAS mutation.
Control	adjacent lung tissue
	Adjacent and histologically normal, non-tumorous lung tissue samples from patients with lung adenocarcinoma.

Relative Expression (log2-ratio):-3.397541
Number of Samples:93 / 98

Experimental	lung adenocarcinoma study 3
	Primary adenocarcinoma samples from the lung of patients with different stages and smoking status.
Control	adjacent lung tissue
	Adjacent, histologically normal and non-neoplastic tissue sample from the lung of patients with primary adenocarcinoma of the lung. Patients had different stages and smoking status.

Relative Expression (log2-ratio):-3.2241287
Number of Samples:10 / 11

Experimental	diphenylcyclopropenone study 1 (early)
	Skin biopsy samples of healthy volunteers exposed to diphenylcyclopropenone (diphencyprone; DPCP) for 3 days. ATC code:---
Control	placebo treated skin tissue
	Skin biopsy samples of healthy volunteers exposed to placebo for 3 days.

Relative Expression (log2-ratio):-3.2197313
Number of Samples:24 / 20

Experimental	lung adenocarcinoma study 6 (EGFR mut)
	Primary tumor sample from patients with stage II adenocarcinoma carrying an EGFR mutation.
Control	adjacent lung tissue
	Adjacent and histologically normal, non-tumorous lung tissue samples from patients with lung adenocarcinoma.

Relative Expression (log2-ratio):3.1541605
Number of Samples:6 / 10

Experimental	diphenylcyclopropenone study 1 (late)
	Skin biopsy samples of healthy volunteers exposed to diphenylcyclopropenone (diphencyprone; DPCP) for 4 to 8 months. ATC code:---
Control	diphenylcyclopropenone study 1 (early)
	Skin biopsy samples of healthy volunteers exposed to diphenylcyclopropenone (diphencyprone; DPCP) for 3 days. ATC code:---